covid-19 drug | sciencenewsnet.in

Breaking News

Alcohol-Induced Blackouts May Be Linked to How a Person Drinks, Not Just How Much

Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms

American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes

Newer antibiotics underprescribed for highly resistant infections

RCT finds calories may be more important than meal timing when it comes to weight loss

Chula Ranks No.1 in Thailand for 32 Subjects in the QS World University Rankings by Subject 2024

Researchers to share expertise at international conference on mine water, reclamation

Physical field technologies to improve extraction and quality of extracted juices

$4.7 million award to help researchers prevent adolescent alcohol use

Lightweight and flexible yet strong? Versatile fibers with dramatically improved energy storage capacity

19 Apr, 2024

Montefiore-Einstein Researchers Test Whether Molnupiravir Can Prevent COVID-19

November 4, 2021 sarah JonasFeature

As part of a recently launched international phase 3 clinical trial, Montefiore Health System and Albert Einstein College of Medicine are investigating whether the Merck antiviral pill, molnupiravir, now approved in Britain for treating COVID-19, can prevent COVID-19 in unvaccinated individuals living with people who have contracted the disease. Montefiore-Einstein is the first and only New York State site for the trial and was selected due to its diverse patient population and expertise in clinical trials of COVID-19 and other infectious diseases.